Director/PDMR Shareholding
Archer Daniels Midland Co.
n/a
12:15 19/04/24
Rentokil Initial plc (the Company)
The Company hereby announces that awards granted under the Rentokil Initial plc Performance Share Plan (PSP) to Alain Moffroid (a person discharging managerial responsibility) over a total of 236,711 shares have today been exercised with the shares being retained in full.
The relevant notification set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Alain Moffroid
| ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Managing Director, Pacific
| ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Rentokil Initial plc | ||||
b)
| LEI
| 549300VN4WV7Z6T14K68 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of 1p each
ISIN: GB00B082RF11
| ||||
b)
| Nature of the transaction
| Exercise of awards made under the Company's Performance Share Plan (PSP).
| ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
236,711 shares
-
| ||||
e)
| Date of the transaction
| 5 August 2019 | ||||
f)
| Place of the transaction
| Outside a trading venue |
Enquiries:
Catherine Stead, Deputy Company Secretary Rentokil Initial plc 01276 607444
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.